Back to search results

Connect-Home: Alzheimer's Disease and Related Dementias

This study is testing an intervention called Connect-Home ADRD. This program helps staff at skilled nursing facilities (SNFs) better support patients with Alzheimer's disease and related dementias (ADRD) and their caregivers when they move from the SNF to home, assisted living, or long-term care. The study aims to see if Connect-Home ADRD can reduce the stress caregivers feel and improve neuropsychiatric symptoms (like agitation or depression) in patients 30 days after they leave the SNF. You might be able to join if you are an English-speaking patient with dementia planning to discharge from an SNF, and you have an English-speaking caregiver willing to participate. The study is currently recruiting 360 patient-caregiver pairs, but the overall status is unclear.

Study design
This is an interventional study that will involve 360 patient-caregiver pairs. Skilled nursing facilities will be randomly assigned to either receive the Connect-Home ADRD intervention or not.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Caregiver strain and patient neuropsychiatric symptoms will be measured 30 days after discharge from the SNF.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06840587

Connect-Home: Alzheimer's Disease and Related Dementias

Recruiting
NAAges 19+InterventionalSupportive care
University of North Carolina, Chapel Hill
~360 participants
Updated 2026-03-30 on ClinicalTrials.gov
What's tested:Connect-Home ADRD

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Caregiver Strain
Measured over 30 days after discharge from SNF
+1 more outcome measured

Conditions

Alzheimer Disease
Dementia

Explore related trials

Alzheimer's DiseaseDementia

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Mark Toles, PhD, RN · PRINCIPAL_INVESTIGATOR · University of North Carolina, Chapel Hill

Who to contact

Molly Lynch, MS
[email protected]
9198438874
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ability to speak English
Goal of discharge to home, assisted living, or long-term care
Diagnosis of dementia
Having a caregiver willing to participate
Ability to speak English
Legally authorized representative (LAR) who also provides support for the person with ADRD
Location within 120 miles of UNC-Chapel Hill
Admission of at least 75 SNF patients per year

Exclusion

Planned hospital readmission for procedures or treatments within 30 days post enrollment.
LAR is a court-appointed guardian.

What this trial measures

  • Caregiver Strain30 days after discharge from SNF

    Modified Caregiver Strain Index Score (MCSI): 13 yes-no items, measure indicators of caregiver strain over the past 30 days. Summary score ranges from 0-26, higher scores indicating greater strain.

  • Patient Neuropsychiatric Symptoms30 days after discharge from SNF

    Neuropsychiatric Inventory-Q (NPI-Q): 12 items on a 3-point scale, measures presence and severity of neuropsychiatric symptoms over the past 30 days. Summary score ranges from 0-36, higher scores associated with more severe symptoms.